The image is from Wikipedia Commons
Heinz Edgar Lehmann
|Born||(1911-07-17)July 17, 1911
|Died||April 7, 1999(1999-04-07) (aged 87)|
|Awards||Order of Canada|
Hospital work in Canada
In 1947, he was appointed the clinical director of Montreal's Douglas Hospital. From 1971 to 1975, he was the chair of the McGill University Department of Psychiatry. He was also a humane lecturer in psychiatry in 1952, and was able to give empathetic lectures on the plight of people suffering from anxiety, depression obsessions, paranoia etc. No one to that time had been able to understand or help schizophrenic patients, who filled mental hospitals around the world, so when chlorpromazine showed some promise he helped to promote it in North America and start the drug revolution. He was ahead of his time in that he supported research in the use of the active ingredient psilocybin to alleviate anxiety.
Le Dain Commission
From 1969 to 1972, he was one of the five members of the Le Dain Commission, a royal commission appointed in Canada to study the non-medical use of drugs. He was an advocate for decriminalization of marijuana.
In 1973, he was a member of the Nomenclature Committee of the American Psychiatric Association that decided to drop homosexuality from the Diagnostic and Statistical Manual of Mental Disorders, i.e. to depathologize it.
Honors and awards
Heinz Lehmann Award
In 1999, the Canadian College of Neuropsychopharmacology established the Heinz Lehmann Award in his honor, given in recognition of outstanding contributions to research in neuropsychopharmacology in Canada.
- Paris, Joel. "Heinz Lehmann: A Pioneer of Modern Psychiatry". Canadian Psychiatric Association. Archived from the original on September 26, 2006. Retrieved April 26, 2006.
- "Canadian Who's Who 1997 entry". Archived from the original on August 11, 2007. Retrieved April 26, 2006.
- This page is based on the Wikipedia article Heinz Lehmann; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA.